Mumbai, May 15 -- Revenue from operations jumped 41.86% to Rs 387.29 crore in Q4 FY26.

The company reported a profit before exceptional items and tax of Rs 8.74 crore in Q4 FY26 compared with a loss before exceptional items and tax of Rs 2.10 crore in Q4 FY25. It reported exceptional gain of Rs 0.86 crore during the quarter.

EBITDA increased 21% to Rs 61.7 crore in Q4 FY26, compared with Rs 51 crore in Q4 FY25. EBITDA margin redcued to 15.8% in Q4 FY26 compared with 18.3% in Q4 FY25.

During the quarter, revenue from base business jumped 36% YoY to Rs 307 crore while revenue from Ibuprofen business climbed 61% YoY to Rs 849 crore.

On full year basis, the company reported consolidated net loss of Rs 7.41 crore in FY26 compared with net ...